An Import Alert Is Not a Recall: Reading Olympus 89-04 Into a Spares File

Two FDA documents name the same five Olympus devices, and the dates printed on them do not agree.

The letter to health care providers is dated October 20, 2026, and it lists all five under a block headed "Effective October 20, 2026": the Endocapsule Small Intestinal Capsule Endoscope Set MAJ-2027, the Evis Exera II Small Intestinal Videoscope SIF-Q180, the Endoeye Flex Deflectable Videoscope LTF-S190-10, and two bronchovideoscopes, BF-1TH1100 and BF-H1100. The Import Alert 89-04 page carries a different field entirely: "Published Date: 10/19/2026".

Neither date is an error, and neither one changes what happens to a patient this morning. What they decide is the question a spares file exists to answer — which document, and which field on it, you cite when someone asks on what date a scope became affected.

This article is written for the person holding that file: the endoscopy suite's equipment manager, biomedical engineering, procurement and stores, and the receiving desk of an independent service organisation. It is about reading two published documents against each other. It is not a repair procedure and not clinical guidance, and nothing here tells anyone how to use a scope on a patient. It is also not authorised, endorsed or sponsored by Olympus or by any other manufacturer named below; the names appear because they are the names on the documents. No price appears anywhere in this article, and nothing in it promises that any shipment clears, any alert lifts, or any device gets repaired.

Three actions that arrive in one news cycle and do three different jobs

Warning letter, import alert and recall get read as stages of one event. They are three different instruments, addressed to three different parties, doing three different things.

Action	The document and what identifies it	Who it is addressed to	What it can compel	What it does not change
Warning letter	Olympus Medical Systems Corporation, CMS #729208, October 7, 2026, opening "Dear Mr. White"	The firm's quality system, at named facilities	A written reply "within fifteen business days from the date you receive this letter"	Names no model, and moves nothing in your store room
Import alert	Import Alert # 89-04, Type: DWPE, Published Date 10/19/2026, titled "Detention Without Physical Examination of Devices from Firms that Have not met Device Quality System Requirements"	FDA field divisions — and, through them, whoever ships	"Divisions may detain, without physical examination, products from the manufacturers identified in the Red List for this import alert."	Does not ask anyone to stop using a device
Recall	The firm's recall customer notification letter	A specific device and its lot	Instructions for units already installed	Does not change the entry status of anything at the border

Keep three sentences apart, because they answer three different questions. The warning letter changes whether this firm can keep shipping into the United States. The import alert changes whether a particular shipment can enter. The recall changes what you do with the unit already in the room.

The refusal path is not a fourth event. The warning letter writes it itself: failure to address violations "may result in the FDA refusing admission of the devices manufactured by your firm into the United States under section 801(a) of the FD&C Act", and devices under that authority "may be detained or refused admission". The import alert is the border-facing face of the same chain, which is why the two documents share a subject and not a format.

Nor does the warning letter name models. What it names is facilities and systems: the devices manufactured at the Hachioji, Aomori, Hinode, Shirakawa, Hamburg, and Brooklyn Park facilities "are adulterated within the meaning of section 501(h) of the Act, 21 U.S.C. § 351(h), in that the methods used in, or the facilities or controls used for, their manufacture, packing, storage, or installation are not in conformity" with the quality system requirements. That is the reason the letter's model table can look like a separate story: it is the same plants, re-cut into customs language.

The Red List is filed by plant and product code, not by specialty

The letter groups its table by effective date. The Red List groups by plant, then by product code, then by a description line. A model can appear in more than one place, and where it appears has nothing to do with what the device does in a procedure.

Model, as the letter prints it	DI in the letter	Where it sits on the Red List	Product code and the description line
Endocapsule Small Intestinal Capsule Endoscope Set	MAJ-2027 / 04953170328268	Hinode Plant, and again at Shirakawa, both Date Published 10/19/2026	78 N - - EZ, "System, Imaging, Gastrointestinal, Wireless, Capsule"; line reads "Endocapsule Small Intestinal Capsule Endoscope Set; MAJ-2027"
Evis Exera II Small Intestinal Videoscope	SIF-Q180 / 04953170339943	Shirakawa, Date Published 10/19/2026	78 F - - DA, "Enteroscope"; line reads "Evis Exera II Small Intestinal Videoscope; SIF-Q180"
Endoeye Flex Deflectable Videoscope	LTF-S190-10 / 04953170310386; 04953170434662	Shirakawa, twice, Date Published 10/19/2026	78 F - - GB, "Ureteroscope", line reading "LTF-190-10-3D, URF-V, LTF-S190-10"; and 85 H - - ET, "Laparoscope, Gynecologic (And Accessories)", line reading "LTF-190-10-3D, LTF-S190-10"
Bronchovideoscope	BF-1TH1100 / 04953170424199	Aizu Olympus, Date Published 06/24/2025; and Shirakawa, Date Published 10/19/2026	77 E - - OQ, "Bronchoscope (Flexible Or Rigid)"
Bronchovideoscope	BF-H1100 / 04953170424229	Same two rows as BF-1TH1100	77 E - - OQ, "Bronchoscope (Flexible Or Rigid)"

The gap between the second and third columns is the part worth carrying away. LTF-S190-10 does not sit on a bronchoscope row. It sits on a ureteroscope row and on a gynaecologic laparoscope row. Search the alert by clinical category and this model is invisible; search it by the model string as printed and it surfaces twice.

Every Olympus description on that page closes with the same parenthetical: "(Capital equipment only for all devices identified)". It looks like boilerplate. It is the sentence that decides whether a spare part order is inside the alert or outside it, and the next section but one comes back to it.

The two bronchoscopes carry a June date on the alert

Aizu Olympus Co., Ltd. is the block with the odd date. Its "Date Published" reads 06/24/2025, and the bronchoscope description line inside it begins "BRONCHOSCOPE (FLEXIBLE OR RIGID); BF-1TH1100; BF-H1100; BF-MP190F; BF-XT190; ...". Both of the models the letter lists under October 20 were already registered on the Red List before that block existed in its current form.

There are two readings of how that happens, and choosing between them is FDA's job, not this article's:

1. The letter counts a registration per plant, so what is new on October 20 is the Shirakawa row for these two models — a row whose own Date Published field reads 10/19/2026. The Aizu row was already there in June.
2. The Aizu row was edited at some point and its Date Published field did not move with the edit.

The Red List publishes no version number and no change history, so the public page cannot separate those two. What the page does support is narrower and still useful: the registration at Aizu carries a June date, and a second registration for the same two models sits at Shirakawa with a Date Published of 10/19/2026.

The letter's own timeline is a third voice, and it is worth quoting rather than paraphrasing. Under 10/20/2026 it says: "The FDA updated the letter to health care providers to include certain enteroscopes and ingestible telemetric gastrointestinal capsule imaging systems placed on import alert, broadening the scope of the letter to include devices manufactured at locations in Japan." Two device families, named. The table's October 20 block, meanwhile, carries an enteroscope, a capsule system, an Endoeye and two bronchovideoscopes. Read the block header for what took effect on that date; do not read "added" into a table that prints "Effective".

For the file, the consequence is one line long. Write the date off the Red List row, not off a news report and not off the letter's header. That row's date is the field a reviewer will ask about, and it is the one field almost nobody copies.

What the capital-equipment bracket does to a spares order

Two statements describe one boundary. The Red List description ends "(Capital equipment only for all devices identified)". The letter tells providers to "be aware that the import alert does not apply to related products (such as replacement parts, connectors, or single use consumables) used with the devices subject to import alert." One is written for the inspector, one for the user; together they say the object of the alert is the complete system, not the parts and consumables that go with it.

That covers the ordinary case. It does not cover the two ways people get it wrong.

The first is treating the exemption as wider than it is. What is exempt is a related product used with an affected device. A second complete system bought as a backup is not a replacement part, and calling it one on a purchase order does not change what it is. Whether a given shipment clears is decided by the entry line it was filed under, and that question belongs to whoever files the entry — not to the receiving dock, which can only see what arrived.

The second is treating the bracket as a permission. It says capital equipment is what the detention authority reaches; it does not say parts circulate freely, and it does not say an affected system is safe to keep running without the maintenance you already owe it.

Where geprobe sits in this: we are a third-party supplier of ultrasound probes and parts and a repairer, and the devices named on this alert are flexible endoscope systems, which are not in the repair classes we work on. Our work is on endoscope-style transesophageal probes, endocavity and 4D volume transducers. That distinction is the reason this article stops at documents: the alert says nothing about repairing anything, and we are not the party that can tell you whether a specific scope is fit for a procedure. Nothing here is a quotation, lead time or availability statement for any Olympus model, and no price is quoted.

Three lines to add to the file this week

The fleet list does not need rebuilding. It needs three fields per affected model, because those are the three a reviewer will ask for.

1. Model string exactly as printed, plus the DI. Copy the model from the device label rather than from the purchase order's short name, and copy the DI from the letter's table, remembering that one model can carry two — LTF-S190-10 carries 04953170310386 and 04953170434662. The DI answers which version of the device this is. The Red List answers which plant it came from. Those are different questions, and a fleet list usually holds only the first. Where a model string and a label disagree, the record-keeping problem is the same one that runs through specification sheets, and it is worth its own read: which specification lines actually change the device.
2. The Red List row: plant, product code, and the description line as printed. That is the line you re-check next quarter, and it is the reason a category search comes back empty.
3. The date you checked, beside the alert's own Published Date — 10/19/2026 on the page read for this article. The Red List changes without announcing what changed. The date is the only evidence of which version you were reading.

None of those three lines require you to agree with the alert, its scope, or its underlying findings. They record what the documents said on a date.

Three sentences about the scopes already in use

The part of the letter that reaches the clinical floor is four lines long, and it is quieter than the coverage suggests.

• Devices in use can stay in use: "users may continue using them if they are not experiencing any problems with the devices".
• Damaged devices, and devices that failed a leak test, cannot: "Do not use damaged devices or those that have failed a leak test, as they could be a potential source of contamination".
• Inspection and maintenance continue on the manufacturer's schedule: "Develop schedules for routine inspection and periodic maintenance in accordance with manufacturer's instructions".

Read the causality carefully, because it is easy to invert. These three lines are not a tightening triggered by the alert. They are the letter restating obligations that already applied, and it restates them because readers will otherwise assume an import alert must mean something new about their scopes. It does not. The alert governs entry at the border; it does not govern your department.

The leak test line is the only one of the three that separates a scope you may use from a scope you may not, and the reason it separates them is fluid ingress rather than the alert. That mechanism has its own article: what a leak test actually asks, and when a pass is the wrong answer.

Answering "are we affected" without guessing

The answer is assembled from three fields, and it is only as good as the weakest of them: the DI from the letter's table, the row on the Red List, and the date you read that row.

With all three, the answer is specific and citable. With two, the honest answer is "unknown", and "unknown" is a better entry in a compliance file than "no" — because it is the answer that sends someone back to the page. A fleet list that says "not affected" without a date and a row number is not recording a finding; it is recording an assumption, and it will be the assumption that gets tested.

The documents will keep changing, and the fields that matter will keep being the boring ones: the plant, the product code, the description line, the published date. Those are the parts of a regulatory page that survive the news cycle around it.